Biomarkers in Inflammatory Myopathies—An Expanded Definition
Biomarkers as parameters of pathophysiological conditions can be of outmost relevance for inflammatory myopathies. They are particularly warranted to inform about diagnostic, prognostic, and therapeutic questions. As biomarkers become more and more relevant in daily routine, this review focusses on...
Main Authors: | Olivier Benveniste, Hans-Hilmar Goebel, Werner Stenzel |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2019.00554/full |
Similar Items
-
Investigating idiopathic inflammatory myopathy; initial cross speciality experience with use of the extended myositis antibody panel
by: Antoinette O'Connor, et al.
Published: (2017-05-01) -
Clinical usefulness of autoantibodies in idiopathic inflammatory myositis
by: Ignacio eGarcia-De La Torre
Published: (2015-06-01) -
Disease Specific Autoantibodies in Idiopathic Inflammatory Myopathies
by: Bruno Stuhlmüller, et al.
Published: (2019-05-01) -
Myositis autoantibodies in a racially diverse population of children with idiopathic inflammatory myopathies
by: Megan Mariko Perron, et al.
Published: (2021-06-01) -
Role of myositis-specific autoantibodies in personalized therapy
by: Anand N Malaviya, et al.
Published: (2018-01-01)